AUPQ314799A0 - Bone cell factor - Google Patents

Bone cell factor

Info

Publication number
AUPQ314799A0
AUPQ314799A0 AUPQ3147A AUPQ314799A AUPQ314799A0 AU PQ314799 A0 AUPQ314799 A0 AU PQ314799A0 AU PQ3147 A AUPQ3147 A AU PQ3147A AU PQ314799 A AUPQ314799 A AU PQ314799A AU PQ314799 A0 AUPQ314799 A0 AU PQ314799A0
Authority
AU
Australia
Prior art keywords
cell factor
bone cell
bone
factor
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ3147A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WESTERN AUSTRALIA THE, University of
Original Assignee
University of Western Australia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Western Australia filed Critical University of Western Australia
Priority to AUPQ3147A priority Critical patent/AUPQ314799A0/en
Publication of AUPQ314799A0 publication Critical patent/AUPQ314799A0/en
Priority to AU78894/00A priority patent/AU7889400A/en
Priority to PCT/AU2000/001202 priority patent/WO2001023549A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
AUPQ3147A 1999-09-29 1999-09-29 Bone cell factor Abandoned AUPQ314799A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPQ3147A AUPQ314799A0 (en) 1999-09-29 1999-09-29 Bone cell factor
AU78894/00A AU7889400A (en) 1999-09-29 2000-09-29 Rat osteoclast differentiation factor
PCT/AU2000/001202 WO2001023549A1 (en) 1999-09-29 2000-09-29 Rat osteoclast differentiation factor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ3147A AUPQ314799A0 (en) 1999-09-29 1999-09-29 Bone cell factor

Publications (1)

Publication Number Publication Date
AUPQ314799A0 true AUPQ314799A0 (en) 1999-10-21

Family

ID=3817311

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ3147A Abandoned AUPQ314799A0 (en) 1999-09-29 1999-09-29 Bone cell factor

Country Status (2)

Country Link
AU (1) AUPQ314799A0 (en)
WO (1) WO2001023549A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2003203A1 (en) 1996-12-23 2008-12-17 Immunex Corporation Ligand for receptor activator of nf-kappa b, ligand is member of TNF superfamily
US6316408B1 (en) 1997-04-16 2001-11-13 Amgen Inc. Methods of use for osetoprotegerin binding protein receptors
EP2009025B1 (en) 1998-05-14 2011-07-27 Immunex Corporation Method of inhibiting osteoclast activity
US6884598B2 (en) 2000-09-22 2005-04-26 Immunex Corporation Screening assays for agonists and antagonists of receptor activator of NF-κB
ES2674888T3 (en) 2001-06-26 2018-07-04 Amgen Inc. OPGL antibodies
CA2481074A1 (en) * 2002-04-05 2003-10-23 Amgen Inc. Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors
CA2508773C (en) 2002-12-10 2013-08-27 Schering-Plough Ltd. Canine rankl and methods for preparing and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2003203A1 (en) * 1996-12-23 2008-12-17 Immunex Corporation Ligand for receptor activator of nf-kappa b, ligand is member of TNF superfamily
DE122010000049I1 (en) * 1997-04-15 2011-05-05 Daiichi Sankyo Co Ltd NEW PROTEIN AND METHOD FOR THE PRODUCTION THEREOF
ID23855A (en) * 1997-04-16 2000-05-25 Amgen Inc OSTEOPROTEGERIN AND RECEPTOR BINDER PROTEINS
WO1999029865A2 (en) * 1997-12-12 1999-06-17 The Rockefeller University A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
CN1318105A (en) * 1998-09-15 2001-10-17 M&E生物技术公司 Methods for down-regulating osteoprotegerin ligand activity
JP2000102390A (en) * 1998-09-30 2000-04-11 Snow Brand Milk Prod Co Ltd Dna and production of protein using the same

Also Published As

Publication number Publication date
WO2001023549A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU2624801A (en) Intervertebral implants
AU7059300A (en) Immediate provisional implant
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU5287000A (en) Parallel x-ray nanotomography
AU2411100A (en) Humidifier
GB9904905D0 (en) Cells
AU6955100A (en) Battery
AU5043600A (en) Battery
AU1106401A (en) Battery
AU5171600A (en) Battery
AU4115400A (en) Short-circuiter
AU5691800A (en) Structure
AU1174801A (en) Humidifier
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU6179400A (en) Multi-photodetector unit cell
AU2201501A (en) Structure
AUPQ314799A0 (en) Bone cell factor
AU2699800A (en) Organoceramics
AU4916900A (en) Benzofuranylsulfonates
EP1128451A4 (en) Cell
AU4561600A (en) Benzofuranylaminoalcohols
AU6006800A (en) Treating cells
AU5003800A (en) Implant system

Legal Events

Date Code Title Description
NAA1 Application designating australia and claiming priority from australian document

Ref document number: 7889400

Country of ref document: AU